Moorside Pharma Developments Limited - Accounts to registrar (filleted) - small 18.2

REGISTERED NUMBER: 07930921 (England and Wales)

Unaudited Financial Statements for the Year Ended 28th February 2019

for

Moorside Pharma Developments Limited

Page

Balance Sheet

1

Fixed assets

501,851

541,140

Current assets

367,166

334,617

Creditors

Amounts falling due within one year

(280,241

)

(255,449

)

Net current assets

86,925

79,168

Total assets less current liabilities

588,776

620,308

Creditors

Amounts falling due after more than one year

548,971

587,950

Net assets

39,805

32,358

Capital and reserves

39,805

32,358

Note to the financial statements

1.	Statutory information

Moorside Pharma Developments Limited is a private company, limited by shares , registered in England and Wales. The

company's registered number and registered office address are as below:

Registered number:

07930921

Registered office:

372 Dudley Hill Road

Bradford

West Yorkshire

BD2 3AA

The company is entitled to exemption from audit under Section 477 of the Companies Act 2006 for the year ended 28th February 2019.

The members have not required the company to obtain an audit of its financial statements for the year ended 28th February 2019 in accordance with Section 476 of the Companies Act 2006.

The directors acknowledge their responsibilities for:

(a)	ensuring that the company keeps accounting records which comply with Sections 386 and 387 of the Companies Act 2006 and

(b)

preparing financial statements which give a true and fair view of the state of affairs of the company as at the end of each financial year and of its profit or loss for each financial year in accordance with the requirements of Sections 394 and 395 and which otherwise comply with the requirements of the Companies Act 2006 relating to financial statements, so far as applicable to the company.

The financial statements have been prepared in accordance with the micro-entity provisions and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved by the Board of Directors on 29th November 2019 and were signed on its behalf by:

P Hodgson - Director